Department of Defense HIV/AIDS Prevention Program
Defense Health Agency Contracting Activity - DHACA · Department of Defense
At a glance
Department of Defense HIV/AIDS Prevention Program is an open federal cooperative agreement opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due September 18, 2027. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.350 (Department of Defense HIV/AIDS Prevention Program).
Summary assembled from the official notice's fields. The official notice governs.
Key facts
- Sep 19, 2022Posted
- Sep 18, 2027Application deadlinenext date
- Oct 18, 2027Archived
- Posted
- Sep 19, 2022
- Close date
- Sep 18, 2027
- Archive date
- Oct 18, 2027
- Award floor
- Not specified
- Award ceiling
- Not specified
- Est. total funding
- Not specified
- Expected awards
- 10
- Cost sharing
- Not required
- Funding instrument
- Cooperative Agreement
- Opportunity category
- Discretionary
Typical awards for this program (SAM.gov listing for ALN 12.350, not this notice): $200,000 to $7,000,000
Who can apply
- Unrestricted (any entity type)
A quick check against the listed applicant types — other requirements in the notice still apply.
Based on the published notice. Review the official notice for complete eligibility requirements.
What it funds
Official synopsis as published by the agency, formatted for readability.
ATTENTION: This announcement will be revised regularly to incorporate country specific narratives (Attachment 1 of the announcement) with information vital to the content of application. Potential applicants interested in applying to this announcement should click 'Subscribe' to be notified of future revisions.
DoD HIV/AID Prevention Program's (DHAPP) objective, through the PEPFAR program, is to save lives, prevent HIV infections, and accelerate progress toward achieving HIV/AIDS epidemic control and to support the development of interventions and programs in military health systems that address these issues. DHAPP works with militaries of foreign countries to devise plans based on the following process:
- Meet with key partners in country to determine provisional major program areas and other technical assistance needs.
- Adapt DHAPP support to a country’s need for prevention, care and/or treatment of its HIV/AIDS situation based on an assessment of the country’s epidemic, and more specifically, in that country’s military.
- Strengthen the military capacity for ownership and behavioral changes over the long term.
- Consider program design by leveraging assets with other country partners who have/had successful prevention, care, and/or treatment efforts.
- Focus on prevention, care and/or treatment impact aligned with national implementation plans.
- Implement and monitor programs to ensure accountability and sustainability.
Countries and their militaries need strong evidenced based HIV programs with measurable courses of action that demonstrate the following specific attributes. Priorities for DHAPP include the following but are subject to change.
- Support and ownership from the military sector.
- Development of plans of action and support for military policies that further HIV epidemic control.
- Alignment with PEPFAR and national strategies and priorities.
- Testing and treatment expansion to meet 2020 goals of 90-90-90 and 2030 goals of 95-95-95 for people living with HIV. (The first goal is identifying 90/95 percent of all HIV-positive individuals in the population; the second goal is linking 90/95 percent of all those identified HIV positive people to consistent antiretroviral treatment; and the last goal is reaching 90/95 percent of all those on antiretroviral treatment to attain viral suppression.)
- Care and treatment plans should use the “Treat All” approach with differentiated models of care including tuberculosis (TB), hepatitis, cervical cancer in HIV positive women, other sexually transmitted infections (STI) other opportunistic infections, and care for those with advanced HIV disease.
- Reduction of mother-to-child transmission of HIV.
- Combination prevention using biomedical, behavioral and structural support for sexual transmission of HIV and other STI.
- Prevention packages for specific populations including a comprehensive package for Key Populations (KP), Priority Populations, and prevention interventions for young people.
- Stigma and discrimination reduction associated with HIV infection.
- Program monitoring to collect and report on PEPFAR indicators, ensure quality of service delivery using clinical and laboratory monitoring tools and to take rapid corrective action based on results.
- Strengthen HIV data collection systems for improved clinical decision making and program management.
- Promoting sustainability through capacity building of the military partner.
- Transition to Local Partners: Local partners are encouraged to apply to this announcement.
To sustain epidemic control, it is critical that the full range of HIV prevention and treatment services are owned and operated by local institutions, governments, and community-based and community-led organizations – regardless of current antiretroviral (ARV) coverage levels. The intent of the transitioning to local partners is to increase the delivery of direct HIV services, along with non-direct services provided at the site, and establish sufficient capacity, capability, and durability of these local partners to ensure successful, long-term, local partner engagement and impact.
Full announcement & documents
The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.
How to apply
0 of 8 done · progress saved in this browser
Assistance Listing
What is an ALN?Reported obligations under ALN 12.350
Historical data · not a predictionWho was funded under ALN 12.350
Historical data · not a predictionSince October 1, 2023, 65 grant awards had funding actions under Department of Defense HIV/AIDS Prevention Program, with 14 sub-awards passed on to other organizations. These are program-wide awards, not awards from this specific notice.
- JHPIEGO CORP$26.4M
- CENTRE FOR INFECTIOUS DISEASE RESEARCH IN ZAMBIA$25.2M
- UNIVERSITY RESEARCH CO., LLC$12.5M
- ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION$9.32M
- GLOBAL SCIENTIFIC SOLUTIONS FOR HEALTH LLC$9.01M
Agency contact (as published)
Christopher Meinberg Grantor
ebony.s.simmons.civ@health.mil
3016192657
Quick answers
When is the deadline for “Department of Defense HIV/AIDS Prevention Program”?
According to the official notice, applications are due September 18, 2027. Confirm the deadline and submission time on Grants.gov before applying.
Who is eligible to apply for “Department of Defense HIV/AIDS Prevention Program”?
The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.
How do I apply for “Department of Defense HIV/AIDS Prevention Program”?
Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity W81XWH-22-DHAPP), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.
Related open opportunities
Matched on shared Assistance Listings, agency, categories and eligible applicant types.
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Defense Health Agency Contracting Activity - DHACA- Award range
- Amount not specified
- Closes
- Sep 30, 2027
- Who can apply
- Unrestricted (any entity type)
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
Defense Health Agency Contracting Activity - DHACA- Award range
- $750K – $50M
- Closes
- Jul 31, 2028
- Who can apply
- Unrestricted (any entity type)
Limited Competition: International epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Dec 3, 2025 (est.)
- Who can apply
- Public colleges & universities, 501(c)(3) nonprofits, Private colleges & universities and 1 more
Notice of Intent to Publish a Funding Opportunity Announcement for HIV Pediatric, Adolescent and Maternal Clinical Trials
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Mar 25, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more
Centers for AIDS Research (CFAR)
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Aug 19, 2026 (est.)
- Who can apply
- State governments, County governments, City or township governments and 12 more
Martin Delaney Collaboratories for HIV Cure Research
National Institutes of Health- Award range
- Amount not specified
- Est. close
- Aug 19, 2026 (est.)
- Who can apply
- State governments, County governments, Independent school districts and 8 more